Dashboard
Manage Tickers

NVONOVO NORDISK A S

NYSE novonordisk.com


$ 146.95 $ 4.63 (3.25 %)    

Tuesday, 25-Jun-2024 15:59:48 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 146.91
$ 145.53
$ 0.00 x 0
$ 0.00 x 0
$ 144.79 - $ 148.15
$ 74.66 - $ 148.15
6,191,265
na
662,564
$ 0.64
$ 0.00
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

novo-nordisks-older-generation-weight-loss-drug-saxenda-associated-with-decreased-bone-mass-density-study-shows
Novo Nordisk's Older Generation Weight-Los...
06/25/2024 18:12:26

Novo Nordisk's Saxenda study published in JAMA Network Open reveals significant declines in bone density among patients, ra...

bmo-capital-maintains-outperform-on-novo-nordisk-maintains-163-price-target
BMO Capital Maintains Outperform on Novo N...
06/25/2024 16:41:04

BMO Capital analyst Evan David Seigerman maintains Novo Nordisk (NYSE:NVO) with a Outperform and maintains $163 price target.

why-novo-nordisk-shares-are-trading-higher-tuesday
Why Novo Nordisk Shares Are Trading Higher...
06/25/2024 15:58:10

The company's weight loss drug Wegovy has been approved in China, the second most populated country that is estimated to ha...

a-closer-look-at-novo-nordisks-options-market-dynamics
A Closer Look at Novo Nordisk's Options Ma...
06/25/2024 15:31:17

novo-drug-saxenda-increases-bone-health-risks-study-finds-researcher-says-bone-health-risks-also-apply-to-ozempic-wegovy
Novo Drug Saxenda Increases Bone Health Ri...
06/25/2024 15:02:53

- Bloomberg 

novo-nordisk-surges-nearly-3-after-weight-loss-drug-wegovy-wins-approval-in-china
Novo Nordisk Surges Nearly 3% After Weight...
06/25/2024 09:44:44

Novo Nordisk's weight loss drug Wegovy has received approval in China, representing a notable achievement for the Danish ph...

wegovy-ozempic-maker-novo-nordisk-to-invest-41b-in-us-manufacturing-doubling-plant-size-to-meet-surging-demand-for-weight-loss-drugs
Wegovy, Ozempic Maker Novo Nordisk To Inve...
06/25/2024 04:41:24

Novo Nordisk A/S is set to invest $4.1 billion in expanding its U.S. manufacturing operations to meet the increasing demand for...

us-senate-health-committee-chairman-sanders-announces-novo-nordisk-ceo-to-testify-before-committee-on-september-24
U.S. Senate Health Committee Chairman Sand...
06/24/2024 19:15:35

- Reuters

regeneron-pharmaceuticals-approach-to-improve-quality-of-weight-loss-has-merit-goldman-sachs
Regeneron Pharmaceuticals' Approach To Imp...
06/24/2024 18:36:01

Regeneron Pharmaceuticals released data from a Phase 1 study on garetosmab and trevogrumab at the ADA meeting, showing signific...

novo-nordisk-to-invest-41-billion-in-north-carolina-facility
Novo Nordisk To Invest $4.1 Billion In Nor...
06/24/2024 18:16:34

- Bloomberg Citing Emailed Statement

will-novo-nordisk-building-fires-serve-as-a-catalyst-for-eli-lilly-redditors-see-a-stock-split-for-us-company-very-likely
Will Novo Nordisk Building Fires Serve As ...
06/24/2024 18:08:51

Eli Lilly's stock may rise due to supply issues at competitor Novo Nordisk, according to Reddit users. Its weight loss drug...

novo-nordisks-ozempic-semaglutide-1mg-shows-reduced-risk-of-kidney-disease-related-events-in-phase-3-flow-trial
Novo Nordisk's Ozempic (Semaglutide) 1mg S...
06/24/2024 17:35:47

Label Extension Application Accepted For FDA Review; Demonstrates Superiority Over Placebo For All Secondary Outcomes; Fewer Se...

Core News & Articles
China's Medical Products Authority Approve...
06/24/2024 12:57:09

Core News & Articles
CORRECTION: Novo Nordisk Ticker is "NVO"
06/24/2024 12:56:41

novo-nordisks-wegovy-demonstrates-greater-weight-loss-in-women-with-heart-condition
Novo Nordisk's Wegovy Demonstrates Greater...
06/24/2024 07:17:42

The greater weight loss in women did not result in significantly better improvements in heart failure symptoms.

Core News & Articles
'House panel weighs new plan for Medicare ...
06/21/2024 18:42:14

https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/

gilead-sciences-faces-wall-street-speculation-about-obesity-drugs-despite-focus-on-liver-treatments
Gilead Sciences Faces Wall Street Speculat...
06/21/2024 15:42:22

Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatme...

move-aside-ozempic-wegovy-denmarks-new-drug-just-showed-positive-results-for-weightloss
Move Aside Ozempic, WeGovy: Denmark's New ...
06/21/2024 12:12:28

As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the dr...

nestle-carefully-targets-weight-loss-drug-users-with-new-food-line
Nestle Carefully Targets Weight-Loss Drug ...
06/21/2024 10:18:15

Nestle's new Vital Pursuit brand targets individuals on weight-loss drugs without mentioning medications on packaging, addr...

german-drug-developer-evotec-seeks-adviser-input-as-takeover-concerns-mount
German Drug Developer Evotec Seeks Adviser...
06/20/2024 17:46:42

Evotec consults defense advisers following a significant share price decline, raising concerns about a potential takeover.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)